Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C
Clinical trial NCT01327729 · UNKNOWN
Trial details
- NCT number
- NCT01327729
- Sponsor
- BioGeneric Pharma
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-04-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.